[1]
Z. A. MIHÁLY, “Validation of the Diagnostic Value of Nuclear Matrix Protein 22 Depending on Tumoral Stage and Grade”, Appl Med Inform, vol. 32, no. 1, pp. 61–68, Feb. 2013.